Robert A Avery1, Eugene I Hwang2, Hiroshi Ishikawa3, Maria T Acosta4, Kelly A Hutcheson5, Domiciano Santos6, Dina J Zand7, Lindsay B Kilburn2, Kenneth N Rosenbaum7, Brian R Rood2, Joel S Schuman3, Roger J Packer8. 1. The Gilbert Family Neurofibromatosis Institute, Children's National Medical Center, Washington, DC2Department of Neurology, Children's National Medical Center, Washington, DC3Department of Ophthalmology, Children's National Medical Center, Washington, DC7. 2. Department of Oncology, Children's National Medical Center, Washington, DC7The Brain Tumor Institute, Children's National Medical Center, Washington, DC. 3. University of Pittsburgh Medical Center Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania10Department of Bioengineering. 4. The Gilbert Family Neurofibromatosis Institute, Children's National Medical Center, Washington, DC2Department of Neurology, Children's National Medical Center, Washington, DC8Center for Neuroscience and Behavior, Children's National Medical Center, Washin. 5. Department of Ophthalmology, Children's National Medical Center, Washington, DC. 6. Department of Anesthesiology, Children's National Medical Center, Washington, DC. 7. Department of Genetics, Children's National Medical Center, Washington, DC. 8. The Gilbert Family Neurofibromatosis Institute, Children's National Medical Center, Washington, DC2Department of Neurology, Children's National Medical Center, Washington, DC6Department of Oncology, Children's National Medical Center, Washington, DC7The B.
Abstract
IMPORTANCE: Monitoring young children with optic pathway gliomas (OPGs) for visual deterioration can be difficult owing to age-related noncompliance. Optical coherence tomography (OCT) measures of retinal nerve fiber layer (RNFL) thickness have been proposed as a surrogate marker of vision but this technique is also limited by patient cooperation. OBJECTIVE: To determine whether measures of circumpapillary RNFL thickness, acquired with handheld OCT (HH-OCT) during sedation, can differentiate between young children with and without vision loss from OPGs. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of a prospective observational study was conducted at a tertiary-care children's hospital. Children with an OPG (sporadic or secondary to neurofibromatosis type 1) who were cooperative for visual acuity testing, but required sedation to complete magnetic resonance imaging, underwent HH-OCT imaging of the circumpapillary RNFL while sedated. MAIN OUTCOMES AND MEASURES: Area under the curve of the receiver operating characteristic, sensitivity, specificity, positive predictive value, and negative predictive value of the average and quadrant-specific RNFL thicknesses. RESULTS: Thirty-three children (64 eyes) met inclusion criteria (median age, 4.8 years; range, 1.8-12.6 years). In children with vision loss (abnormal visual acuity and/or visual field), RNFL thickness was decreased in all quadrants compared with the normal-vision group (P < .001 for all comparisons). Using abnormal criteria of less than 5% and less than 1%, the area under the curve was highest for the average RNFL thickness (0.96 and 0.97, respectively) compared with specific anatomic quadrants. The highest discrimination and predictive values were demonstrated for participants with 2 or more quadrants meeting less than 5% (sensitivity = 93.3; specificity = 97.9; positive predictive value = 93.3; and negative predictive value = 97.9) and less than 1% (sensitivity = 93.3; specificity = 100; positive predictive value = 100; and negative predictive value = 98.0) criteria. CONCLUSIONS AND RELEVANCE: Measures of RNFL thickness acquired with HH-OCT during sedation can differentiate between young children with and without vision loss from OPGs. For young children who do not cooperate with vision testing, HH-OCT measures may be a surrogate marker of vision. Longitudinal studies are needed to delineate the temporal relationship between RNFL decline and vision loss.
IMPORTANCE: Monitoring young children with optic pathway gliomas (OPGs) for visual deterioration can be difficult owing to age-related noncompliance. Optical coherence tomography (OCT) measures of retinal nerve fiber layer (RNFL) thickness have been proposed as a surrogate marker of vision but this technique is also limited by patient cooperation. OBJECTIVE: To determine whether measures of circumpapillary RNFL thickness, acquired with handheld OCT (HH-OCT) during sedation, can differentiate between young children with and without vision loss from OPGs. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of a prospective observational study was conducted at a tertiary-care children's hospital. Children with an OPG (sporadic or secondary to neurofibromatosis type 1) who were cooperative for visual acuity testing, but required sedation to complete magnetic resonance imaging, underwent HH-OCT imaging of the circumpapillary RNFL while sedated. MAIN OUTCOMES AND MEASURES: Area under the curve of the receiver operating characteristic, sensitivity, specificity, positive predictive value, and negative predictive value of the average and quadrant-specific RNFL thicknesses. RESULTS: Thirty-three children (64 eyes) met inclusion criteria (median age, 4.8 years; range, 1.8-12.6 years). In children with vision loss (abnormal visual acuity and/or visual field), RNFL thickness was decreased in all quadrants compared with the normal-vision group (P < .001 for all comparisons). Using abnormal criteria of less than 5% and less than 1%, the area under the curve was highest for the average RNFL thickness (0.96 and 0.97, respectively) compared with specific anatomic quadrants. The highest discrimination and predictive values were demonstrated for participants with 2 or more quadrants meeting less than 5% (sensitivity = 93.3; specificity = 97.9; positive predictive value = 93.3; and negative predictive value = 97.9) and less than 1% (sensitivity = 93.3; specificity = 100; positive predictive value = 100; and negative predictive value = 98.0) criteria. CONCLUSIONS AND RELEVANCE: Measures of RNFL thickness acquired with HH-OCT during sedation can differentiate between young children with and without vision loss from OPGs. For young children who do not cooperate with vision testing, HH-OCT measures may be a surrogate marker of vision. Longitudinal studies are needed to delineate the temporal relationship between RNFL decline and vision loss.
Authors: Ramiro S Maldonado; Rachelle V O'Connell; Neeru Sarin; Sharon F Freedman; David K Wallace; C Michael Cotten; Katrina P Winter; Sandra Stinnett; Stephanie J Chiu; Joseph A Izatt; Sina Farsiu; Cynthia A Toth Journal: Ophthalmology Date: 2011-09-21 Impact factor: 12.079
Authors: Robert A Avery; Grant T Liu; Michael J Fisher; Graham E Quinn; Jean B Belasco; Peter C Phillips; Maureen G Maguire; Laura J Balcer Journal: Am J Ophthalmol Date: 2011-01-12 Impact factor: 5.258
Authors: Lan Chang; Mays A El-Dairi; Tamiesha A Frempong; Erica L Burner; M Tariq Bhatti; Terri L Young; Fawn Leigh Journal: J AAPOS Date: 2010-12 Impact factor: 1.220
Authors: Ramiro S Maldonado; Joseph A Izatt; Neeru Sarin; David K Wallace; Sharon Freedman; C Michael Cotten; Cynthia A Toth Journal: Invest Ophthalmol Vis Sci Date: 2010-01-13 Impact factor: 4.799
Authors: Scott R Lambert; Edward G Buckley; Carolyn Drews-Botsch; Lindreth DuBois; Eugenie Hartmann; Michael J Lynn; David A Plager; M Edward Wilson Journal: Arch Ophthalmol Date: 2010-01
Authors: Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa Journal: Am J Ophthalmol Date: 2014-07-25 Impact factor: 5.258
Authors: Robert A Avery; Avital Cnaan; Joel S Schuman; Chieh-Li Chen; Natalie C Glaug; Roger J Packer; Graham E Quinn; Hiroshi Ishikawa Journal: Am J Ophthalmol Date: 2014-06-28 Impact factor: 5.258
Authors: Adam L Rothman; Monica B Sevilla; Sharon F Freedman; Amy Y Tong; Vincent Tai; Du Tran-Viet; Sina Farsiu; Cynthia A Toth; Mays A El-Dairi Journal: Am J Ophthalmol Date: 2015-01-26 Impact factor: 5.258
Authors: Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery Journal: J Neuroophthalmol Date: 2017-09 Impact factor: 3.042
Authors: Adam L Rothman; Monica B Sevilla; Shwetha Mangalesh; Kathryn E Gustafson; Laura Edwards; C Michael Cotten; Joshua S Shimony; Carolyn E Pizoli; Mays A El-Dairi; Sharon F Freedman; Cynthia A Toth Journal: Am J Ophthalmol Date: 2015-09-18 Impact factor: 5.258